Overweight Recommendation Issued On DRTS By Barclays

May 28, 2026 04:15:03 am

Source: KlickAnalytics

2026-05-28 04:15:03 ET

Barclays analyst issues OVERWEIGHT recommendation for DRTS on May 28, 2026 07:36AM ET.

DRTS was trading at $10.29 at issue of the analyst recommendation.

The overall analyst consensus : BUY.

Current analyst recommendations are : 4 - Buy, 1 - Hold recommendations .

Latest 10 recommendations

Alpha Tau Medical Ltd.

10.85% G/L:

$10.01 Last:

1,830,626 Volume:

$9.27 Open:

June 03, 2026 08:30:00 am

June 01, 2026 09:00:00 am

May 28, 2026 05:15:03 am

May 28, 2026 04:15:03 am

Market Cap $624,275,171

Float 56,235,657

Insiders Ownership N/A

Institutions 20

Short Percent N/A

Industry Biotechnology & Life Sciences

Sector Healthcare

Country IL

City Jerusalem